期刊文献+
共找到365篇文章
< 1 2 19 >
每页显示 20 50 100
Relationships between bird communities and vegetation structure in Honghuaerji, northern Inner Mongolia 被引量:2
1
作者 王文 丸山直树 +2 位作者 刘伯文 森本英人 高中信 《Journal of Forestry Research》 SCIE CAS CSCD 2002年第4期294-298,337,共5页
The survey on bird communities was conducted by the belt-style method in six different sample plots in the Honghua抏rji Forests area in the northern Inner Mongolia in June 2001 and totally 28 bird species were recorde... The survey on bird communities was conducted by the belt-style method in six different sample plots in the Honghua抏rji Forests area in the northern Inner Mongolia in June 2001 and totally 28 bird species were recorded. Vegetation investigation was carried out in five 10 m×10 m quadrats at each plot. The asymptotic regression function formulae were adopted to identify the relationships between the vegetation coverage and the numbers of bird species and individuals. The analytical results showed that the changes of species number and density of bird as well as the formation of bird communities follow the changes of forest type and the total foliage. Both the number of bird species and their density decreased with the de-crease of total foliage. The similarity of bird community was very low at the breeding time. In the same classification of cluster, no similarity was higher than 0.65, which indicated that the composition of species had a great difference between all the bird communities. The bird breeding density was closely related to forest growth stage. From the bare grassland ecosystem to cli-max ecosystem, the density of bird species showed a gradually increasing trend. 展开更多
关键词 Bird community Vegetation structure honghua抏rji Northern Inner Mongolia
在线阅读 下载PDF
Effects of Honghua preserved amniotic membrane on scar healing in experimental glaucoma surgery 被引量:16
2
作者 Yi Shao Yao Yu +7 位作者 Qiu-Ping Liu Jing-Ming Li Fei Dong Xin Huang Chong-Gang Pei Ping Tu Hen-Hui Li Gui-Ping Gao 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2014年第2期226-231,共6页
AIM:To investigate the efficacy and safety of Honghua preserved amniotic membrane(AM)for preventing scar formation of the filtering bleb in a rabbit model of glaucoma trabeculectomy surgery.METHODS:Totally 36 rabbits(... AIM:To investigate the efficacy and safety of Honghua preserved amniotic membrane(AM)for preventing scar formation of the filtering bleb in a rabbit model of glaucoma trabeculectomy surgery.METHODS:Totally 36 rabbits(36 eyes)were randomly divided into 3 groups:the experimental group(ocular trabeculectomy in combination with Honghua preserved AM transplantation),the control group(ocular trabeculectomy surgery in combination with AM implantation),and the blank group(single trabeculectomy).Clinical observations[including intraocular pressure(IOP),filtering blebs and complications],MassonTrichrome staining,real-time quantitative reverse transcription-polymerase chain reaction(real-time PCR),Western blot were performed on different time points(D1,D7,D14,D21 and D56)after the surgery.RESULTS:After operated for 14d,there were statistically significant differences in the filtering blebs compared to the situation before operation(P【0.05),whereas no statistically difference on that among three groups(P】0.05).After 21d,the IOP of experimental group was lowest(P【0.05).There was significant difference between control group and blank group(P【0.05).On postoperative D14,the mean number of fibroblasts in the experimental group was significantlylower(40.6±10.2)compared to those in the control group(54.4±10.8)and blank group(68.2±11.6)(P【0.05,respectively).The mean numbers of the macrophage in the experimental and control groups were respcitively significantly lower versus the blank group(P【0.05,P【0.05,respectively).Compared to that in blank group,the level of transforming growth factor-β(TGF-β1)expression in sclera and conjunctival areas was reduced in the experimental and control groups on protein and mRNA level(P【0.05),but not significant difference between these two groups(P】0.05).CONCLUSION:The trabeculectory surgery with Honghua preserved AM can control IOP,sustain the functional filtration bleb,inhibit the proliferation of fibroblasts and open the filtrating pathway on the rabbit glaucoma models. 展开更多
关键词 amniotic membrane trabeculectomy honghua injection implant transforming growth factor-β scar formation
原文传递
Pharmacokinetic parameters investigation on interaction between Danshen injection and Honghua injection 被引量:1
3
作者 YU Fan LI Guo-zhuan +2 位作者 GUO Dong-dong PENG Dai-yin CHEN Wei-dong 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2016年第10期1045-1045,共1页
OBJECTIVE Danshen injection and Honghua injection,traditional Chinese medicine(TCM)injections,made from the extracts of Salvia miltiorrhiza Bge.and Carthamus tinctorius L.,have a potential to be developed into the use... OBJECTIVE Danshen injection and Honghua injection,traditional Chinese medicine(TCM)injections,made from the extracts of Salvia miltiorrhiza Bge.and Carthamus tinctorius L.,have a potential to be developed into the useful drugs for the.As the common TCM injections,Danshen injection is often combined with Honghua injection to treat cardiovascular disease.The purpose of this study was to investigate the pharmacokinetic parameters of Honghua injection combined with Danshen injection when they were coadministered intravenously in human and rats through the tail vein.METHODS Single and multiple doses of Danshen injection to study Danshen injection on Honghua injection pharmacokinetics parameters and single and multiple doses of Honghua injection to study Honghua injection on Danshen injection pharmacokinetics parameters.The plasma concentrations of hydroxysafflor A(HSYA)and tanshinol and salvianolic acid B were determined by the reliable high-performance liquid chromatography(HPLC)method.The concentrations of HSYA in urine of rats and human were also determined by HPLC method.DAS 2.1.1software was adopted for calculating the pharmacokinetic parameters.RESULTS The simultaneous intravenous Honghua injection and salvia miltiorrhiza injiection significantly altered the pharmacokinetic parameters of both injections when compared with the individual intravenous administration of each injection.The area under the concentration-timecurve(AUC)and maximum plasma concentration(Cmax)of HSYA and tanshinol and salvianolic acid B were significantly increased.The cumulative urine excretion of HSYA in human and rats during 24 h was decreased after two drugs were administered simultaneously by the intravenous.CONCLUSION Honghua injection and Danshen injection interact with each other following simultaneous intravenous and they have a synergistic action.This experiment has identified the pharmacokinetic parameters and provided a rationale for the clinical use of the drug combination. 展开更多
关键词 pharmacokinetic parameters honghua injection Danshen injection
暂未订购
Reef Types and Sedimentation Characteristics of Changxing Formation in Manyue-Honghua Section of Kaixian,Northeastern Sichuan Basin 被引量:1
4
作者 吴立群 焦养泉 +2 位作者 荣辉 王瑞 李荣 《Journal of Earth Science》 SCIE CAS CSCD 2012年第4期490-505,共16页
In Changxing (长兴) stage, Manyue (满月)-Honghua (红花) Section of Kaixian (开县), northeastern Sichuan (四川) Province was located in the platform-margin slope, which was the advantage area of reef-shoal de... In Changxing (长兴) stage, Manyue (满月)-Honghua (红花) Section of Kaixian (开县), northeastern Sichuan (四川) Province was located in the platform-margin slope, which was the advantage area of reef-shoal depositional system developing. The strata of Changxing Formation are continuously exposed on both Honghua Section and Manyue Section. Four and two depositional cycles ean be identified in Honghua Section and Manyue Section, respectively. They are all platform-margin reef-shoal deposits. Their lithologic associations have obvious sequence, which is as follows: micrite bioclast limestone, bafflestone, bindstone, framestone, and bioclast limestone, in order from below. The paleontological assemblages are controlled by water depth and genetic facies. Six paleontological as- semblages can be identified in Honghua Section and Manyue Section; they are coral-calcareous algaecalcareous sponge assemblage, calcareous sponge-calcareous algae assemblage, calcareous spongecalcareous algae-coral-bryozoan assemblage, calcareous sponge-calcareous algae-hydra assemblage, calcareous sponge-calcareous algae-hydra-bryozoan assemblage, and calcareous sponge-calcareous algae-hydra-bryozoan-coral assemblage. The study of lithologic associations and paleontological assemblages indicates that the water body shallowed upward in both the growth cycle of a single reef and the higher-grade depositional cycle. According to the water depth types of reef (bioherm) developing, three different reef-shoal depositional systems can be identified in study area: deep-water-type bioherm, transitional-type reef (bioherm), and more shallow-water-type reef. 展开更多
关键词 northeastern Sichuan Manyue-honghua Section Changxing Formation reef.
原文传递
Research of the molecular mechanism of Hai Honghua medicinal liquor in the treatment of fracture based on network pharmacology combined with molecular docking 被引量:2
5
作者 Die Qian Cheng-Xun He +4 位作者 Qing Zhang Xiao-Ting Huang Jun Zhao Chi Xu Hong Zhang 《TMR Integrative Medicine》 2023年第12期1-9,共9页
Background:Hai Honghua medicinal liquor(HHML),a famous hospital formula composed of 19 traditional Chinese medicines,has been successfully applied in treating soft tissue injury,fresh closed fracture,limb dysfunction ... Background:Hai Honghua medicinal liquor(HHML),a famous hospital formula composed of 19 traditional Chinese medicines,has been successfully applied in treating soft tissue injury,fresh closed fracture,limb dysfunction after fracture healing,shoulder,neck and leg pain,knee joint pain and other clinical multiple diseases for 30 years in clinical.However,research on the material basis of HHML for the treatment of fracture healing-related disorders is still in a gap.Therefore,it is particularly important to explore the active ingredients,core targets and potential pharmacological mechanisms of HHML to promote fracture healing.Methods:We screened the core active components of each traditional Chinese medicine in formula and its action targets through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and Encyclopedia of Traditional Chinese Medicine database.The fracture related targets were retrieved from several different public databases,including GeneCards,Online Mendelian Inheritance in Man,DisGeNET and Therapeutic Target Database.Bioinformatics analysis to obtain key bioactive components,underlying targets and signaling pathways,containing the Venn diagram of the intersection with components and diseases gene targets,protein–protein interaction,as well as the Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes analysis,and finally molecular docking.Results:A total of 249 bioactive ingredients of HHML and 325 HHML-fracture-related targets were screened.The network analysis revealed that quercetin,luteolin,kaempferol,Licochalcone A,naringenin and 8-Isopentenyl-kaempferol may be potential candidate agents.Multiple targets are involved including TP53,MAPK3,STAT3,AKT1,MAPK1,HSP90AA1,ESR1 and PIK3CA may be closely linked targets.PI3K-AKT signaling pathway may play a significant role of HHML in treatment of fracture.What’s more,molecular docking suggested that 8-isopentenyl kaempferol,glycyrrhiza chalcone A,and naringenin bound to AKT1,PIK3CA,and ESR1,respectively,exhibiting lower energy and more stable characteristics.Conclusions:The findings indicate the potential active ingredients,target proteins and molecular mechanisms of HHML for the treatment of fractures to provide the exact idea for the next research on the mechanism of action of HHML formula for fracture treatment. 展开更多
关键词 Hai honghua medicinal liquor fracture healing network pharmacology molecular docking PI3K/AKT signal pathway
暂未订购
Can Tibetan medicine Honghua Ruyi pills relieve endometriosisassociated dysmenorrhea?Protocol for a randomized placebocontrolled trial
6
作者 Mei Han Jiahui Cao +7 位作者 Jiali Wei Hui Luo Chaoqin Yu Xuefang Liang Nyangmotse Guoyan Yang Huilan Du Jianping Liu 《Journal of Traditional Chinese Medical Sciences》 CAS 2024年第1期78-85,共8页
Objective:To provide high-quality clinical evidence of the efficacy of Tibetan medicine Honghua Ruyi(HHRY)pills for endometriosis-associated dysmenorrhea.Methods:This study constitutes a multicenter,randomized,double-... Objective:To provide high-quality clinical evidence of the efficacy of Tibetan medicine Honghua Ruyi(HHRY)pills for endometriosis-associated dysmenorrhea.Methods:This study constitutes a multicenter,randomized,double-blind,placebo-controlled trial encompassing a three-menstrual cycle intervention followed by a three-menstrual cycle follow-up period.A total of 164 eligible females with endometriosis-associated dysmenorrhea were randomly divided into HHRY pills and placebo groups in a 1:1 ratio.The primary outcome included dysmenorrhea symptoms assessed using Visual Analog Scale(VAS)scores and quality of life,whereas the secondary outcome measures included the maximum VAS for non-menstrual pelvic pain,duration of pain episodes(in days),frequency and quantity of the consumption of ibuprofen sustained-release capsules(or other non-steroidal anti-inflammatory drugs),and days off work/study for staff/student due to dysmenorrhea,ovarian cyst,and/or pelvic nodule size.The safety was monitored throughout the treatment period.All the analyses were based on the intention-to-treat principle.For continuous outcomes,simple or multiple linear regressions were used to estimate the differences between the HHRY pills and placebo groups,with categorical data expressed as the number and percentage of occurrences.Differences were compared using the chi-square test or Fisher's exact test.The predefined analysis was adjusted for concomitant treatment,a variable considered to be associated with outcomes but unaffected by treatment allocation.Estimates of treatment effects were reported with 95%confidence intervals.Two-tailed P values≤.05 were considered statistically significant.Conclusion:Positive results from this trial,upon completion would provide robust evidence for the efficacy and safety of HHRY pills in treating dysmenorrhea in patients with endometriosis. 展开更多
关键词 ENDOMETRIOSIS DYSMENORRHEA honghua Ruyi pills Randomized controlled trial Traditional Chinese medicine
暂未订购
Integration of network pharmacology and bone marrow mesenchymal stem cells experimental research to reveal the molecular mechanisms for Hai Honghua medicinal liquor against osteoporosis
7
作者 Die Qian Chi Xu +3 位作者 Cheng-Xun He Mei-Yan Li Juan Guo Hong Zhang 《Integrative Medicine Discovery》 2024年第3期1-11,共11页
Background:Hai Honghua medicinal liquor(HHML)formula has been used in clinical practice for a long time,mainly for the treatment of freshly closed fractures,to promote osteogenesis,to increase bone mass,and thus to pr... Background:Hai Honghua medicinal liquor(HHML)formula has been used in clinical practice for a long time,mainly for the treatment of freshly closed fractures,to promote osteogenesis,to increase bone mass,and thus to promote fracture healing.However,the underlying mechanisms of HHML in the treatment of osteoporosis(OP)are still unclear.Methods:Firstly,Traditional Chinese Medicines Systems Pharmacology Database and Analysis Platform and The Encyclopedia of Traditional Chinese Medicine were used to screen the targets of the active compounds of HHML.At the same time,OP targets were identified through GeneCards,Online Mendelian Inheritance in Man,DisGeNET,Therapeutic Target Database,Comparative Toxicogenomics Database and Human Phenotype Ontology databases.Next,protein-protein interaction and pathway networks were constructed for compound-disease common targets,and core targets and compounds were screened for molecular docking.Furthermore,rat bone marrow mesenchymal stem cells were extracted as model cells,and the osteogenic effects of HHML were verified via in vitro experiments.Results:Total of 343 common targets of HHML-OP and the top 10 target proteins in the protein-protein interaction network are TP53,AKT1,STAT3,HSP90AA1,ESR1,TNF,IL6,MAPK1,MAPK3 and MAPK8.Enrichment analysis yielded that the key molecular pathway was the PI3K/Akt signaling pathway.Molecular docking analysis showed that baicalein,erysodienone and naringenin docked with the target proteins AKT1,STAT3 and TP53,respectively,with low binding energy and high affinity.In addition,In vitro experiments demonstrated that HHML promoted the proliferation of bone marrow mesenchymal stem cells;compared with the control group,HHML-treated cells showed enhanced alkaline phosphatase staining,promoted the expression of OCN,RUNX2,BSP,and COL1 mRNAs as well as the expression of PI3K and AKT phosphorylated proteins.Secondly,the expression of target proteins revealed that HHML promoted the phosphorylation of STAT3 protein and inhibited the expression of P53.Conclusions:Our study investigated that HHML treatment with OP promotes bone formation possibly through activation of the PI3K/Akt signaling pathway and may involve STAT3 and TP53 target interactions. 展开更多
关键词 Hai honghua medicinal liquor OSTEOPOROSIS network pharmacology molecular docking PI3K/AKT signal pathway
暂未订购
红花逍遥片对三阴性乳腺癌肝郁气滞证患者PI3K/AKT/mTOR信号通路的影响 被引量:2
8
作者 汪志春 王恒丹 +1 位作者 李森 徐胜昔 《临床合理用药》 2025年第14期29-32,共4页
目的观察红花逍遥片对三阴性乳腺癌肝郁气滞证患者PI3K/AKT/mTOR信号通路的影响,以期为临床乳腺癌防治提供新思路。方法选取2020年1月1日-2023年12月30日九江市第一人民医院收治的三阴性乳腺癌肝郁气滞证患者80例。采用随机数字表法分... 目的观察红花逍遥片对三阴性乳腺癌肝郁气滞证患者PI3K/AKT/mTOR信号通路的影响,以期为临床乳腺癌防治提供新思路。方法选取2020年1月1日-2023年12月30日九江市第一人民医院收治的三阴性乳腺癌肝郁气滞证患者80例。采用随机数字表法分为观察组和对照组,各40例。对照组予密集蒽环类+环磷酰胺序贯密集紫杉醇治疗,观察组在对照组基础上加用红花逍遥片治疗。2组均以21 d为1个疗程,共治疗4个疗程。比较2组用药后PI3K/AKT/mTOR蛋白表达水平,治疗前后中医证候积分、生活质量评分(FACT-B)差异,以及不良反应。结果用药后,观察组PI3K/AKT/mTOR蛋白表达水平均较对照组低(P<0.05或P<0.01);治疗4个疗程后,2组中医证候积分中各项均较治疗前降低,FACT-B评分均较治疗前提高,且观察组变化程度大于对照组(P<0.01)。观察组与对照组不良反应总发生率比较差异无统计学意义(12.50%vs.17.50%,χ^(2)=0.392,P=0.531)。结论红花逍遥片可通过影响三阴性乳腺癌肝郁气滞患者PI3K/AKT/mTOR信号通路,发挥抗癌活性,可作为化疗药物的补充药物提高抗癌活性。 展开更多
关键词 三阴性乳腺癌 肝郁气滞证 红花逍遥片 信号通路
原文传递
丹参-红花药对防治肺动脉高压作用机制的网络药理学分析
9
作者 张磊 闫海峰 +3 位作者 王姗姗 李晓辉 张泽宇 朱翠玲 《河南中医》 2025年第12期1849-1855,共7页
目的:基于网络药理学分析丹参-红花药对防治肺动脉高压(pulmonary hypertension,PH)的作用机制。方法:在中药系统药理学数据库与分析平台检索丹参、红花的化学成分及相关靶点。通过GeneCards、OMIM、DrugBank数据库获取PH相关靶点,将其... 目的:基于网络药理学分析丹参-红花药对防治肺动脉高压(pulmonary hypertension,PH)的作用机制。方法:在中药系统药理学数据库与分析平台检索丹参、红花的化学成分及相关靶点。通过GeneCards、OMIM、DrugBank数据库获取PH相关靶点,将其导入STRING数据库获得蛋白互作关系,并利用Cytoscape-v3.8.2软件进行拓扑分析,筛选PH核心靶点。将核心靶点与丹参、红花的有效成分靶蛋白取交集,获取丹参-红花药对防治PH的潜在靶点。将潜在靶点导入Rx644.0.2软件进行基因本体论(Gene Ontology,GO)富集分析和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)信号通路富集分析。将丹参、红花的有效成分和潜在靶点导入Cytoscape-v 3.8.2软件,构建“成分-靶点”网络,拓扑分析筛选关键靶点及相应有效成分,并运用AutoDock Vina软件进行分子对接。结果:丹参-红花药对共有62种有效成分及212个靶蛋白。通过GeneCards、OMIM、DrugBank数据库筛选出134个PH相关蛋白,与化学成分相关靶点取交集获得46个共同靶点。GO功能富集分析共获得2316个功能项,其中生物学过程2162项、细胞组分29项、分子功能125项;KEGG富集分析共获得166条信号通路。“成分-靶点”网络分析显示,RELA、TP53、JUN、TNF等为关键靶点,槲皮素、木犀草素、黄芩素、山柰酚、丹参酮ⅡA和隐丹参酮等为核心成分。分子对接显示,核心成分与关键靶点对接良好。结论:丹参-红花药对可能通过槲皮素、木犀草素、黄芩素等多种有效成分作用于TNF、RELA、TP53等核心蛋白调控PI3K-AKT、Th17细胞分化、TNF等通路,进而调控氧化应激、细胞增殖、蛋白磷酸化等生物过程发挥防治PH的作用。 展开更多
关键词 肺动脉高压 丹参 红花 药对 网络药理学 分子对接 作用机制
暂未订购
丹参红花方联合LMWH对老年髋部骨折快速康复患者凝血功能及下肢血栓预防的治疗价值 被引量:8
10
作者 张春晓 王立刚 +2 位作者 王磊 陈烨 胡松峰 《辽宁中医药大学学报》 CAS 2025年第1期139-143,共5页
目的观察丹参红花方联合低分子肝素(low molecular weight heparin,LMWH)在老年髋部骨折快速康复治疗过程中对凝血功能及下肢深静脉血栓(lower extremity deep vein thrombosis,LDVT)的临床影响。方法以绍兴市中医院关节骨科2022年10月... 目的观察丹参红花方联合低分子肝素(low molecular weight heparin,LMWH)在老年髋部骨折快速康复治疗过程中对凝血功能及下肢深静脉血栓(lower extremity deep vein thrombosis,LDVT)的临床影响。方法以绍兴市中医院关节骨科2022年10月—2023年4月收治的68例老年不稳定型股骨颈骨折入院72 h内行全髋关节置换术的快速康复治疗患者为研究对象,随机分为两组,对照组34例予低分子肝素钠术后预防性抗凝治疗,治疗组34例予丹参红花方联合低分子肝素钠治疗。记录两组患者手术前后的凝血酶原时间测定(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、D-二聚体、血浆AT-Ⅲ的水平变化及LDVT的发生情况,对两组数据进行统计分析。结果最终完成试验60例,治疗组30例,对照组30例。经统计两组患者术前PT、APTT、TT、D-二聚体、血浆AT-Ⅲ的水平差异无统计学意义(P>0.05);术后第1天、术后第5天,治疗组PT、APTT、TT较同期对照组有所延长(P<0.05),D-二聚体水平较同期对照组下降(P<0.05),血浆AT-Ⅲ活性水平较同期对照组明显提高(P<0.05);术后LDVT事件对比,治疗组较对照组减少(P<0.05)。结论老年髋部骨折快速康复治疗患者的治疗过程中,术后运用丹参红花方联合LMWH的患者,能够有效改善患者凝血功能,明显降低术后D-二聚体水平,提高血浆AT-Ⅲ活性水平,减少术后LDVT发生率,在老年髋部骨折快速康复治疗过程中具有积极意义。 展开更多
关键词 丹参红花方 老年髋部骨折 快速康复 活血化瘀法 下肢静脉血栓
原文传递
桃仁红花煎中活血药与理气药配伍在防治胸痹中的应用研究 被引量:1
11
作者 顾烜烨 张国勇 +2 位作者 周迎春 谢凌鹏 吴玉婷 《实用中医内科杂志》 2025年第1期31-33,共3页
“气为血之帅、血为气之母”,“气血”生理上相互依存,病理上相互影响。“气行则血行,气止则血止……气有一息之不运,则血有一息之不行”。故胸痹血瘀之证,常在活血祛瘀剂中配伍理气之品以助血行,既照顾了气血间“气行则血行”的生理关... “气为血之帅、血为气之母”,“气血”生理上相互依存,病理上相互影响。“气行则血行,气止则血止……气有一息之不运,则血有一息之不行”。故胸痹血瘀之证,常在活血祛瘀剂中配伍理气之品以助血行,既照顾了气血间“气行则血行”的生理关系,又顾及了气滞、血瘀、痰浊、寒邪等病邪于病理上的相互影响。文章从中医学血瘀在介导胸痹发病中的作用及“理气”法与“活血”法配伍在防治胸痹中的应用出发,探讨桃仁红花煎中活血药与理气药配伍在防治胸痹中的应用机制,并进一步阐释“理气活血”法配伍在防治胸痹中的科学内涵。 展开更多
关键词 桃仁红花煎 胸痹 活血法 理气法
原文传递
藏药红花如意丸治疗原发性痛经有效性和安全性的真实世界研究
12
作者 张可隽 牛冰倩 +23 位作者 李倩 靳路阔 罗晓梅 边文会 陈慧娟 焦瑞芹 侯晶晶 郭凤荷 崔珺 方进芬 刘成藏 崔梦姣 宋文文 龚承凤 刘东涌 田桂芳 申卫平 许浪萍 李素芳 陈美霞 高素云 杨爱玲 郝志峰 杨立 《中国新药杂志》 北大核心 2025年第21期2300-2305,共6页
目的:评价藏药红花如意丸(Honghua Ruyi Wan,HHRYW)对原发性痛经(primary dysmenorrhea,PD)患者的疗效及安全性。方法:采用多中心、大样本、自身前后对照临床试验设计,纳入671例PD患者接受HHRYW治疗,比较患者治疗前后的视觉模拟量表(vis... 目的:评价藏药红花如意丸(Honghua Ruyi Wan,HHRYW)对原发性痛经(primary dysmenorrhea,PD)患者的疗效及安全性。方法:采用多中心、大样本、自身前后对照临床试验设计,纳入671例PD患者接受HHRYW治疗,比较患者治疗前后的视觉模拟量表(visual analogue scale,VAS)评分和COX痛经症状量表(COX menstrual symptom scale,CMSS)评分。结果:单独服用HHRYW治疗的PD患者,VAS评分和CMSS评分均较治疗前显著降低(P<0.0001),不同疗程组内和组间VAS评分改善有统计学差异(P<0.0001);PD相关症状的严重程度和持续时间均较治疗前显著降低(P<0.0001);HHRYW对寒凝血瘀型和气滞血瘀型患者的VAS评分改善优于其他证型(P<0.0001)。结论:HHRYW对减轻VAS评分≥4分中重度PD患者的疼痛程度以及改善痛经相关症状疗效显著,尤其对于寒凝血瘀型和气滞血瘀型PD患者疗效较佳,HHRYW具有一定临床推广价值。 展开更多
关键词 原发性痛经 红花如意丸 视觉模拟量表 COX痛经症状量表 临床研究
原文传递
基于网络药理学和分子对接技术探讨桃仁-红花药对治疗心肌缺血的作用机制 被引量:2
13
作者 朱恒岳 柯于鹤 《湖北民族大学学报(医学版)》 2025年第1期15-20,共6页
目的探讨桃仁-红花药对治疗心肌缺血的相关作用机制。方法TCMSP数据库分别检索桃仁、红花得到其有效成分,使用口服生物利用度、类药性作为筛选条件进一步筛选其有效成分,在GeneCards、OMIM数据库上使用检索词“Myocardial ischemia”,... 目的探讨桃仁-红花药对治疗心肌缺血的相关作用机制。方法TCMSP数据库分别检索桃仁、红花得到其有效成分,使用口服生物利用度、类药性作为筛选条件进一步筛选其有效成分,在GeneCards、OMIM数据库上使用检索词“Myocardial ischemia”,得到疾病相关靶点,通过筛选后进一步得到疾病与药物的共同作用靶点,利用Cytoscape软件绘制药物有效成分与疾病靶点的互作图,通过String数据库构建靶点蛋白的互作网络图,并通过GO功能及KEGG信号通路富集分析,最后进行分子对接,确定桃仁-红花药对的主要活性成分。结果得到桃仁-红花药对有效成分45个,疾病潜在靶点3043个,疾病与药物共同靶点146个,KEGG通路富集分析显示显著富集的信号通路包括高级糖基化终末产物-受体信号通路、IL-17信号通路、TNF信号通路、流体剪切应力、前列腺癌等。分子对接显示木犀草素、槲皮素、山柰酚可能为药对的关键活性成分。结论桃仁-红花药对可能通过抑制蛋白质分子环氧合酶2(COX-2),调节环氧合酶1(COX-1),抑制白细胞介素-17(IL-17)信号通路、肿瘤坏死因子(TNF)信号通路来治疗心肌缺血。 展开更多
关键词 桃仁红花 网络药理学 心肌缺血 分子对接
暂未订购
瓜蒌红花甘草汤治疗带状疱疹病毒感染对其中医症候和T淋巴细胞亚群及微炎症状态的影响
14
作者 刘雨琛 林立 +2 位作者 王姗姗 安月鹏 杨素清 《中华医院感染学杂志》 北大核心 2025年第4期513-517,共5页
目的 探讨瓜蒌红花甘草汤对带状疱疹病毒感染患者中医症候、T淋巴细胞亚群及微炎症状态的影响,并评估治疗安全性。方法 选取黑龙江中医药大学附属第一医院2020年12月-2023年12月收治的120例带状疱疹病毒感染患者,分为常规组(阿昔洛韦治... 目的 探讨瓜蒌红花甘草汤对带状疱疹病毒感染患者中医症候、T淋巴细胞亚群及微炎症状态的影响,并评估治疗安全性。方法 选取黑龙江中医药大学附属第一医院2020年12月-2023年12月收治的120例带状疱疹病毒感染患者,分为常规组(阿昔洛韦治疗)和联合组(阿昔洛韦+瓜蒌红花甘草汤治疗),各60例,两组均治疗2周。比较两组治疗2周后的临床疗效,症状控制时间,治疗前和治疗2周后的证候积分、T淋巴细胞亚群水平、疼痛介质及微炎症状态,治疗期间不良反应情况。结果 治疗2周后,联合组疗效优于常规组(P=0.028)。治疗2周后,两组主、次证评分、中医证候总分、CD_(8)^(+)、血清环氧化酶-2(COX-2)、C-反应蛋白(CRP)水平均降低,且联合组以上指标分别为(6.01±0.66)分、(3.96±0.41)分、(9.97±1.01)分、(25.26±3.02)%、(22.16±2.36)ng/ml、(8.62±0.87) mg/L,较常规组更低(P<0.05);CD_(3)^(+)、CD_(4)^(+)、CD_(4)^(+)/CD_(8)^(+)、血清β-内啡肽(β-EP)、白细胞介素(IL)-2水平在两组治疗2周后升高,且联合组以上指标分别为(68.29±6.56)%、(43.03±4.42)%、1.70±0.26、(129.93±13.02)μg/L、(13.96±1.40)pg/ml,高于常规组(P<0.05)。联合组止痛、止疱、结痂及脱痂时间均短于常规组(P<0.05)。两组治疗期间的不良反应发生率差异无统计学意义(P=0.509)。结论 瓜蒌红花甘草汤治疗带状疱疹病毒感染能有效地改善患者免疫功能,缓解疼痛介质及微炎症状态指标,进而有利于控制临床症状和提高临床疗效,且安全性良好。 展开更多
关键词 瓜蒌红花甘草汤 带状疱疹病毒感染 炎症 免疫 疼痛介质
原文传递
蒙药“古日古木-7”质量标准提升研究
15
作者 孙欣缘 郑雅萍 +3 位作者 孙康萌 李旻辉 何春年 肖培根 《中国现代中药》 2025年第1期137-144,共8页
目的:修订和完善“古日古木-7”药品标准,为合理控制“古日古木-7”类药品质量提供科学依据。方法:选择临床常用且现行质量评价标准较低的3种“古日古木-7”药品(德都红花七味丸/散、红花七味丸/散和清肝七味丸/散),分别收集和配伍21份... 目的:修订和完善“古日古木-7”药品标准,为合理控制“古日古木-7”类药品质量提供科学依据。方法:选择临床常用且现行质量评价标准较低的3种“古日古木-7”药品(德都红花七味丸/散、红花七味丸/散和清肝七味丸/散),分别收集和配伍21份代表性样品,以羟基红花黄色素A为指标建立含量测定方法,同时建立能够有效区分不同来源“古日古木-7”的化学特征指纹图谱。结果:3种“古日古木-7”药品中羟基红花黄色素A的质量分数分别为(5.26±0.32)、(4.97±0.94)、(5.21±0.26)mg·g^(-1),差异无统计学意义。建立的特征指纹图谱能够有效区分3种“古日古木-7”药品,其中德都红花七味丸/散特征图谱含有蓝盆花中的特征性成分秦皮乙素,红花七味丸/散含有菊花中的特征性成分木犀草苷和异鼠李素,2种药品均出现明显的诃子中鞣花酸成分的特征峰,而清肝七味丸/散中则没有鞣花酸成分的特征峰,除此以外,还多出香青兰和瞿麦的成分信息。结论:建立了能够同时快速准确测定3种“古日古木-7”药品中的羟基红花黄色素A含量,并规定了含量限度,有利于确保药品的基本质量,建立的特征图谱可以有效区分不同来源的“古日古木-7”药品,从而为“古日古木-7”类药品质量标准提高和临床合理用药提供参考。 展开更多
关键词 “古日古木-7” 质量标准 特征图谱 含量测定 德都红花七味丸/散 红花七味丸/散 清肝七味丸/散
暂未订购
红花多糖提取工艺、结构特征及药理活性研究进展 被引量:1
16
作者 简志敏 张玲声 +3 位作者 钟雪铧 赵飞亚 李婧炜 陶爱恩 《中华中医药学刊》 北大核心 2025年第9期50-57,I0016,共9页
红花(Carthamus tinctorius L.)为菊科草本植物,属于药食两用植物,具有活血通经、散瘀止痛的功效,迄今为止从红花中分离获得多种化学成分,涉及黄酮、生物碱、聚炔、亚精胺、多糖及无机元素等,以黄酮类化合物最多,具有抗心脑血管、免疫... 红花(Carthamus tinctorius L.)为菊科草本植物,属于药食两用植物,具有活血通经、散瘀止痛的功效,迄今为止从红花中分离获得多种化学成分,涉及黄酮、生物碱、聚炔、亚精胺、多糖及无机元素等,以黄酮类化合物最多,具有抗心脑血管、免疫调节、抗炎镇痛、抗肿瘤、抗氧化等多种药理活性。红花多糖是红花的主要药效成分之一。具有免疫调节,抗肿瘤,抗氧化等药理活性,尤其以抗肿瘤作用最为突出,具有潜在研究与开发价值。为此,该研究从提取工艺、分离纯化、结构特征、药理活性和分子机制等方面进行阐释,其中,详细介绍了红花多糖的结构特征。同时,综述了红花多糖的体内、体外和临床生物活性,并对其生物活性的可能机制进行了探讨。最后,对今后的研究工作提出了新的展望为今后红花多糖的研究提出了新的有价值的见解,为红花多糖资源化学成分利用提供参考。 展开更多
关键词 红花多糖 提取工艺 分离纯化 结构鉴定 药理作用 分子机制
原文传递
基于网络药理学探讨丹参-红花药对治疗糖尿病周围神经病变的作用机制 被引量:1
17
作者 陈方飞 刘雅玲 +2 位作者 罗幸 麦小丽 邓小敏 《西部中医药》 2025年第4期47-52,共6页
目的:运用网络药理学方法探讨丹参-红花药对治疗糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)的作用机制。方法:通过中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology database and anal... 目的:运用网络药理学方法探讨丹参-红花药对治疗糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)的作用机制。方法:通过中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology database and analysis platform,TCMSP)检索丹参和红花的活性成分及对应靶点,借助UniProt数据库对靶点进行规范化;通过人类基因数据库(the human gene database,GeneCards)、Disgenet、药物靶标数据库(therapeutic targetdatabase,TTD)、在线人类孟德尔遗传数据库(online mendelian inheritance in man,OMIM)获取DPN的相关靶点,并利用R语言筛选药物与疾病的交集靶点;通过STRING数据库对交集靶点进行蛋白-蛋白互作(protein-protein interactions,PPI)网络分析,并通过Bioconductor平台对交集靶点进行基因本体论(gene ontology,GO)功能富集分析和京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)通路富集分析;通过Cytoscape软件构建丹参-红花药对治疗DPN的“活性成分-疾病靶点”可视化调控网络及PPI调控网络,借助CytoNCA插件筛选并提取出核心调控网络得到的核心活性成分及作用靶点。结果:获得丹参-红花药对73个活性成分,对应215个作用靶点,其中与疾病的交集靶点96个;筛选出槲皮素、山柰酚、木犀草素、丹参酮ⅡA等16个核心活性成分,核心作用靶点包括AKT1、IL-1β等20个;GO功能富集分析涉及2497个条目,主要影响转录因子活性、酶活性、受体活性及生物化学过程调控等过程,KEGG通路富集分析得到158条,涉及到糖尿病并发症中的AGE-RAGE、IL-17、TNF等信号通路。结论:丹参-红花药对通过槲皮素、山柰酚、木犀草素、丹参酮ⅡA等活性成分干预AGE-RAGE等信号通路,并作用于AKT1等靶点,从而发挥治疗DPN的作用。 展开更多
关键词 糖尿病周围神经病变 丹参 红花 网络药理学
暂未订购
丹参-红花药对治疗心脑血管疾病作用机制及临床研究
18
作者 路晶晶 张明雪 《辽宁中医药大学学报》 2025年第2期68-73,共6页
心脑血管疾病作为我国人民首要致死病因,其发病率及致死率呈逐年递增趋势。中药配伍可以发挥协同、拮抗等作用,可增强疗效,扩大用药治疗范围。研究表明,丹参和红花配伍作为活血化瘀类常用药物组合被广泛应用于心脑血管疾病的临床治疗中... 心脑血管疾病作为我国人民首要致死病因,其发病率及致死率呈逐年递增趋势。中药配伍可以发挥协同、拮抗等作用,可增强疗效,扩大用药治疗范围。研究表明,丹参和红花配伍作为活血化瘀类常用药物组合被广泛应用于心脑血管疾病的临床治疗中,如冠心病、心绞痛、脑梗死等。丹参有效成分丹参素、丹酚酸B等与红花中的羟基红花黄色素A为二者配伍的主要活性成分,主要通过降低炎症因子的表达、抗动脉粥样硬化的形成、保护血管内皮、抑制血小板聚集和活化、调节细胞的自噬与凋亡、抗氧化应激、调控多方面通路的传导及相关蛋白的表达等机制发挥作用。该文对丹参-红花药对的物质基础、作用原理、临床运用等方面作出了全面的概括和汇总,希望能够对丹参-红花药对当前研究及其临床应用有所启示,同时也为中医理论中的“异病同治”之“心脑同治”提供充分依据。 展开更多
关键词 丹参 红花 心脑血管疾病 配伍 研究进展
原文传递
肠道菌群对三七-红花有效组分药代动力学影响
19
作者 宋金洋 逯文翰 +1 位作者 刘蓬蓬 郭晓宇 《辽宁中医药大学学报》 2025年第3期21-27,共7页
目的阐明肠道菌群变化对大鼠体内三七-红花有效组分(CNS)主要药效成分的药代动力学影响。方法采用亚胺培南/西司他丁钠腹腔注射1周,诱导拟无菌大鼠模型。正常大鼠和拟无菌大鼠均灌胃CNS后,在不同时间点采集血浆,使用液相色谱串联质谱法(... 目的阐明肠道菌群变化对大鼠体内三七-红花有效组分(CNS)主要药效成分的药代动力学影响。方法采用亚胺培南/西司他丁钠腹腔注射1周,诱导拟无菌大鼠模型。正常大鼠和拟无菌大鼠均灌胃CNS后,在不同时间点采集血浆,使用液相色谱串联质谱法(LC-MS/MS)测定给药后血浆中羟基红花黄色素A(HSYA),三七皂苷R1,人参皂苷Rb1、Rg1、Rd和Re的浓度,并使用DAS 3.0软件计算药代动力学参数。结果通过前期已建立的大体积进样体系,检测CNS中6个主要药效成分的血药浓度。结果显示,与正常大鼠相比,拟无菌大鼠体内药-时曲线下面积(AUC0-t)和最大血药浓度值(Cmax)均升高,其中6个主要药效成分的Cmax差异均具有统计学意义。结论抑制肠道菌群后,会导致CNS中主要药效成分的体内暴露量增加。 展开更多
关键词 三七 红花 心肌缺血 药代动力学 肠道菌群
原文传递
红花如意丸治疗黄褐斑的临床效果
20
作者 陈文静 管宁 +4 位作者 秦天歌 万月 翟烨 黄晶晶 李建红 《中国医药导报》 2025年第29期40-43,50,共5页
目的评价红花如意丸治疗黄褐斑的临床效果及安全性。方法采用随机、双盲、安慰剂对照试验方法,选取2023年4月至2024年3月于北京中医药大学东直门医院皮肤科门诊治疗的64例气滞血瘀证黄褐斑患者。所有患者均依据随机数字表法,按双盲原则... 目的评价红花如意丸治疗黄褐斑的临床效果及安全性。方法采用随机、双盲、安慰剂对照试验方法,选取2023年4月至2024年3月于北京中医药大学东直门医院皮肤科门诊治疗的64例气滞血瘀证黄褐斑患者。所有患者均依据随机数字表法,按双盲原则分配至治疗组或对照组,每组各32例。治疗组予红花如意丸口服,对照组予红花如意丸安慰剂口服,连续治疗8周。观察两组临床疗效、黄褐斑面积和严重指数(MASI)评分、中医证候评分、黄褐斑生活质量(MELASQOL)评分、患者满意度评价,记录所有不良事件。结果治疗组和对照组分别脱落3例,故最终完成试验58例,治疗组和对照组最终均完成29例。治疗组临床疗效优于对照组(P<0.05)。治疗后,治疗组MASI评分、中医证候评分、MELASQOL评分较治疗前降低,且治疗组低于对照组(P<0.05)。治疗组满意度高于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论红花如意丸治疗黄褐斑效果较好,安全性较高。 展开更多
关键词 黄褐斑 红花如意丸 气滞血瘀证 随机对照试验 临床疗效
暂未订购
上一页 1 2 19 下一页 到第
使用帮助 返回顶部